SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Confidence intervals for cost-effectiveness ratios: An application of Fieller's theorem
0 references·16 citing·39 second hopsampled
Confidence intervals for cost-effectiveness ratios: An application of Fieller's theorem (1996)Confidence intervals for cost-effectivene…Regression models for analyzing costs and their determinants in health care: an introductory review (2011)Regression models for analyzi…The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report (2009)The ISPOR Good Practices for …Regression methods for cost-effectiveness analysis with censored data (2004)Regression methods for cost-e…Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel models (2004)Assessing generalisability by…Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses (2001)Quantifying stochastic uncert…Incremental net benefit in randomized clinical trials (2001)Incremental net benefit in ra…Guidelines for Economic Evaluations in Italy: Recommendations from The Italian Group of Pharmacoeconomic Studies (2001)Guidelines for Economic Evalu…Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with Type II diabetes (UKPDS No. 51) (2001)Cost-effectiveness analysis o…Bayesian cost‐effectiveness analysis from clinical trial data (2001)Bayesian cost‐effectiveness a…A framework for cost‐effectiveness analysis from clinical trial data (2001)A framework for cost‐effectiv…Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio (2000)Inference for the Cost-Effect…Performing Cost-Effectiveness Analysis by Integrating Randomized Trial Data with a Comprehensive Decision Model (1999)Performing Cost-Effectiveness…On the use of survival analysis techniques to estimate medical care costs (1999)On the use of survival analys…Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation (1999)Constructing confidence inter…Assessing the costs of healthcare technologies in clinical trials. (1999)Assessing the costs of health…Power and Sample Size Calculations for Stochastic Cost-Effectiveness Analysis (1998)Power and Sample Size Calcula…How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Costs, effects and C/E‐ratios alongside a clinical trial (1994)Cost-Effectiveness in Health and Medicine (1996)Development of a Decision-Analytic Model of Stroke Care in the United States and Europe (2002)Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach (2003)Evidence synthesis, parameter correlation and probabilistic sensitivity analysis (2006)Net Health Benefits (1998)How Sensitive Are Cost-Effectiveness Analyses to Choice of Parametric Distributions? (2005)Including quality attributes in efficiency measures consistent with net benefit: Creating incentives for evidence based medicine in practice (2012)Quality of life and pharmacoeconomics in clinical trials (1996)Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)???Lost in Translation??? (2006)Decision-analytical modelling in health-care economic evaluations (2007)Econometric Analysis of Panel Data (2021)Monte Carlo Simulation (1997)Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation (1997)The Value of Value of Information (2010)A Comparison of Alternative Models for the Demand for Medical Care (1983)In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care (1994)Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis (1995)Predicting the Cost of Illness (1998)Estimating mean hospital cost as a function of length of stay and patient characteristics (2002)Ten-Year Survival and Cost Following Breast Cancer Recurrence: Estimates from SEER-Medicare Data (2007)A theory of justice original editionMethods for the Economic Evaluation of Health Care Programmes (2005)Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare (2018)National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison (2021)Recommendations for Reporting Cost-effectiveness Analyses (1996)Gaussian Process Modeling in Conjunction with Individual Patient Simulation Modeling: A Case Study Describing the Calculation of Cost-Effectiveness Ratios for the Treatment of Established Osteoporosis (2004)Analyses of Cost Data in Economic Evaluations Conducted Alongside Randomized Controlled Trials (2006)10.1007/978-1-4899-4485-6 (2000)Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality? (2002)Health Measurement Scales: A Practical Guide to Their Development and Use (1989)Direct costs associated with depression in old age in Germany (2007)An Improved Set of Standards for Finding Cost for Cost-Effectiveness Analysis (2009)Step-by-step guideline for disease-specific costing studies in low- and middle-income countries: a mixed methodology (2014)Does equity in healthcare spending exist among Indian states? Explaining regional variations from national sample survey data (2017)Global treatment costs of breast cancer by stage: A systematic review (2018)Determinants of healthcare seeking and out-of-pocket expenditures in a “free” healthcare system: evidence from rural Malawi (2020)
this work references cited by second hop· second hop is a sample of the most-cited connections

References

No references inside the corpus for this window.

Cited by

  • 2011Regression models for analyzing costs and their determinants in health care: an introductory review176 cited
  • 1999Assessing the costs of healthcare technologies in clinical trials.150 cited
  • 1999Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation146 cited
  • 1999Performing Cost-Effectiveness Analysis by Integrating Randomized Trial Data with a Comprehensive Decision Model140 cited
  • 2001Guidelines for Economic Evaluations in Italy: Recommendations from The Italian Group of Pharmacoeconomic Studies126 cited
  • 2004Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel models117 cited
  • 1999On the use of survival analysis techniques to estimate medical care costs114 cited
  • 2001Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses112 cited
  • 2001Bayesian cost‐effectiveness analysis from clinical trial data108 cited
  • 2001Incremental net benefit in randomized clinical trials107 cited
  • 2001A framework for cost‐effectiveness analysis from clinical trial data102 cited
  • 2001Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with Type II diabetes (UKPDS No. 51)99 cited
  • 2004Regression methods for cost-effectiveness analysis with censored data

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

92 cited
  • 1998Power and Sample Size Calculations for Stochastic Cost-Effectiveness Analysis88 cited
  • 2009The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report84 cited
  • 2000Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio81 cited